ABK Biomedical

ABK Biomedical was founded in 2012, is headquartered in Halifax, Canada, lists 11–50 employees, and has $104.0M in recorded funding across 5 rounds.

Headquarters
Halifax
Employees
11–50
Founded
2012
Business Model
B2B
Total Funding
$104.0M
Last Round
$35.0M Series DOct 2025
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 6 investors for this company. The full record is or through the API.

About

ABK Biomedical is a Halifax, Nova Scotia-based clinical-stage medical device company, spun out of Dalhousie University in 2012, that designs imageable embolic microsphere products for interventional oncology. Its Eye90 microspheres are used for Y90 radioembolization of liver tumors with in-procedure visualization, while its Easi-Vue embolic microspheres have FDA 510(k) clearance for treating arteriovenous malformations and hypervascular tumors. The company operates GMP manufacturing facilities in Halifax and is running the pivotal ROUTE90 study of Eye90 in unresectable hepatocellular carcinoma.

Summary

ABK Biomedical is a Healthcare company based in Halifax, Canada, founded in 2012. It lists 11–50 employees. It has raised $104.0M in total across 5 rounds, most recently a $35.0M Series D round in Oct 2025. Investors include F-Prime Capital, J.P. Morgan Life Sciences Private Capital and Sante Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series DSeries DOct 2025
$35.0M

Sign up to see all 5 events

Funding: Seed through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Neko Health

Neko Health delivers preventive health scans that combine skin, heart, blood, and body measuremen...

Stockholm, Sweden201–500Artificial Intelligence, Digital Health
Series CTotal funding$1.1BJul 2026
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ABK Biomedical on Indexed.vc
<a href="https://indexed.vc/companies/abk-biomedical"><img src="https://indexed.vc/api/badge/company/abk-biomedical" alt="ABK Biomedical on Indexed.vc" width="260" height="76" /></a>